Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Metabolic Brain Disease
Published in: Metabolic Brain Disease 3/2017

01-06-2017 | Original Article

Serum trace elements are associated with hemostasis, lipid spectrum and inflammatory markers in men suffering from acute ischemic stroke

Authors: Anatoly V. Skalny, Lydmila L. Klimenko, Aliya A. Turna, Maria N. Budanova, Ivan S. Baskakov, Marina S. Savostina, Aksana N. Mazilina, Anatoly I. Deyev, Margarita G. Skalnaya, Alexey A. Tinkov

Published in: Metabolic Brain Disease | Issue 3/2017

Login to get access

Abstract

The primary objective of the study is investigation of the association between trace elements status and hemostasis, lipid spectrum and inflammatory markers in acute ischemic stroke (AIS). A total of 30 men suffering from AIS and 30 healthy controls were involved in the current survey. Blood count, serum lipid spectrum, complement components C4 and C3a, vascular endothelial growth factor (VEGF), S100B protein, NR2 antibodies (NR2Ab), and total antioxidant status (TAS), as well as plasma fibrinogen, and D-dimer levels and activated partial thromboplastin time (APTT) were assessed. Serum trace elements were analyzed using inductively coupled plasma mass spectrometry. AIS patients were characterized by significantly increased fibrinogen, D-dimer, TG, C3a, C4, NR2Ab, and VEGF levels. The leukocyte count, erythrocyte sedimentation rate and serum atherogenic index were also increased in stroke patients. Oppositely, TAS and APTT values, bleeding and blood coagulation time were decreased. AIS patients were characterized by significantly decreased serum Fe and Co concentrations, whereas the level of Cu, I, Li, Mn, Se, Zn, As, Pb, Ni, and especially V and B in serum was significantly increased. Serum V and B tightly correlated with the procoagulant state and inflammatory markers. Multiple regression analysis revealed a significant inverse association between serum Se levels and stroke markers after adjustment for covariates. Therefore, it is hypothesized that elements like vanadium and boron may be closely involved in stroke pathogenesis by modulation of hemostasis and inflammation, whereas the observed increase in Se levels may be considered as a compensatory reaction.
Literature
Abou-Shady EA, Farrag HE, El-Damarawy NA, Mohamed FA, Kamel AM, Massoud AA (1990) In vitro effects of trace elements on blood clotting and platelet function. A-iron, copper, and gold. J Egypt Public Health Ass 66(1–2):21–48
Altamura C, Squitti R, Pasqualetti P, Gaudino C, Palazzo P, Tibuzzi F, Lupoi D, Cortezi M, Rossini PM, Vernieri F (2009) Ceruloplasmin/transferrin system is related to clinical status in acute stroke. Stroke 40(4):1282–1288CrossRefPubMed
Angelova EA, Atanassova PA, Chalakova NT, Dimitrov BD (2008) Associations between serum selenium and total plasma homocysteine during the acute phase of ischaemic stroke. Eur Neurol 60(6):298–303CrossRefPubMed
Assenza G, Zappasodi F, Squitti R, Altamura C, Ventriglia M, Ercolani M, Quattrocchi CC, Lupoi D, Passarelli F, Vernieri F, Rossini PM, Rossini PM (2009) Neuronal functionality assessed by magnetoencephalography is related to oxidative stress system in acute ischemic stroke. NeuroImage 44(4):1267–1273CrossRefPubMed
Baker SJ, Ding CZ, Akama T, Zhang YK, Hernandez V, Xia Y (2009) Therapeutic potential of boron-containing compounds. Future Med Chem 1(7):1275–1288CrossRefPubMed
Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ (2004) Hemostatic function and progressing ischemic stroke D-dimer predicts early clinical progression. Stroke 35(6):1421–1425CrossRefPubMed
Bräuer AU, Savaskan NΕ (2004) Molecular actions of selenium in the brain: neuroprotective mechanisms of an essential trace element. Rev Neurosci 15(1):19–32CrossRefPubMed
Cappola AR, Ladenson PW (2003) Hypothyroidism and atherosclerosis. J Clin Endoc Metab 88(6):2438–2444CrossRef
Carbonell T, Rama R (2007) Iron, oxidative stress and early neurological deterioration in ischemic stroke. Curr Med Chem 14(8):857–874CrossRefPubMed
Cavusoglu E, Eng C, Chopra V, Ruwende C, Yanamadala S, Clark LT, Marmur JD (2007) Usefulness of the serum complement component C4 as a predictor of stroke in patients with known or suspected coronary artery disease referred for coronary angiography. Am J Cardiol 100(2):164–168CrossRefPubMed
Chamorro A (2004) Role of inflammation in stroke and atherothrombosis. Cerebrovasc Dis 17:1–5CrossRef
Cherubini A, Ruggiero C, Polidori MC, Mecocci P (2005) Potential markers of oxidative stress in stroke. Free Radical Bio Med 39(7):841–852CrossRef
Davalos A, Fernandez-Real JM, Ricart W, Soler S, Molins A, Planas E, Genis D (1994) Iron-related damage in acute ischemic stroke. Stroke 25(8):1543–1546CrossRefPubMed
Davalos A, Castillo J, Marrugat J, Fernandez-Real JM, Armengou A, Cacabelos P, Rama R (2000) Body iron stores and early neurologic deterioration in acute cerebral infarction. Neurology 54(8):1568–1574CrossRefPubMed
Franchini M, Targher G, Montagnana M, Lippi G (2008) Iron and thrombosis. Ann Hematol 87(3):167–173CrossRefPubMed
Frederickson CJ, Maret W, Cuajungco MP (2004) Zinc and excitotoxic brain injury: a new model. Neuroscientist 10(1):18–25CrossRefPubMed
Frederickson CJ, Giblin LJ, Krężel A et al (2006) Concentrations of extracellular free zinc (pZn) e in the central nervous system during simple anesthetization, ischemia and reperfusion. Exp Neurol 198(2):285–293CrossRefPubMed
Garza A, Vega R, Soto E (2006) Cellular mechanisms of lead neurotoxicity. Med Sci Monit 12(3):57–65
Go AS, Mozaffarian D, Roger VL, Benjamin EJ et al (2014) Heart disease and stroke statistics-2014 update. Circulation 129(3):28–292
González-Villalva A, Rodriguez-Lara A, Montano V, Lima-Melo A, Ramírez G, Fortoul TI (2009) Blood changes generated after vanadium inhalation. Curr Top Toxicol 6:31–38
González-Villalva A, Piñón-Zárate G, De la Peña DA et al (2011) The effect of vanadium on platelet function. Environ Toxic Phar 32(3):447–456CrossRef
Hao Z, Wu B, Wang D, Lin S, Tao W, Liu M (2013) A cohort study of patients with anemia on admission and fatality after acute ischemic stroke. J Clin Neurosci 20(1):37–42CrossRefPubMed
Hartfield DS, Lowry NJ, Keene DL, Yager JY (1997) Iron deficiency: a cause of stroke in infants and children. Pediatr Neurol 16(1):50–53CrossRefPubMed
He K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willett WC, Ascherio A (2004) Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke 35(1):169–174CrossRefPubMed
Huang J, Upadhyay UM, Tamargo RJ (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66(3):232–245CrossRefPubMed
Inan Ç, Kilinç K, Kotiloğlu E, Akman HO, Kiliç I, Michl J (1998) Antioxidant therapy of cobalt and vitamin E in hemosiderosis. J Lab Clin Med 132(2):157–165CrossRefPubMed
Karadas S, Sayın R, Aslan M et al (2014) Serum levels of trace elements and heavy metals in patients with acute hemorrhagic stroke. J Membrane Biol 247(2):175–180CrossRef
Klimenko LL, Skalny AV, Turna AA, Tinkov AA, Budanova MN, Baskakov IS, Savostina MS, Mazilina AN, Deev AI, Nikonorov AA (2015) Serum trace element profiles, prolactin, and cortisol in transient ischemic attack patients. Biol Trace Elem Res:1–8
Kodali P, Chitta KR, Landero Figueroa JA, Caruso JA, Adeoye O (2012) Detection of metals and metalloproteins in the plasma of stroke patients by mass spectrometry methods. Metallomics 4(10):1077–1087CrossRefPubMedPubMedCentral
Koh JY, Suh SW, Gwag BJ, He YY (1996) The role of zinc in selective neuronal death after transient global cerebral ischemia. Science 272(5264):1013CrossRefPubMed
Kumar V, Gill KD (2009) Aluminium neurotoxicity: neurobehavioural and oxidative aspects. Arch Toxicol 83(11):965–978CrossRefPubMed
Lapenna D, Ciofani G, Bruno C, Pierdomenico SD, Giuliani L, Giamberardino MA, Cuccurullo F (2002) Vanadyl as a catalyst of human lipoprotein oxidation. Biochem Pharmacol 63(3):375–380CrossRefPubMed
Li YV, Zhang JH (2012) Metal ions in stroke pathophysiology. In: Li YV, Zhang JH (eds) Metal ion in stroke. Springer, New York, pp 1–12CrossRef
Liu Z, Li P, Zhao D, Tang H, Guo J (2012) Protection by vanadium, a contemporary treatment approach to both diabetes and focal cerebral ischemia in rats. Biol Trace Elem Res 145(1):66–70CrossRefPubMed
Marniemi J, Alanen E, Impivaara O, Seppänen R, Hakala P, Rajala T, Rönnemaa T (2005) Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis 15(3):188–197CrossRefPubMed
Matsuo R, Ago T, Kamouchi M, Kuroda J, Kuwashiro T, Hata J, Kitazono T (2013) Clinical significance of plasma VEGF value in ischemic stroke-research for biomarkers in ischemic stroke (REBIOS) study. BMC Neurol 13(1):32CrossRefPubMedPubMedCentral
McNicol A, Robertson C, Gerrard JM (1993) Vanadate activates platelets by enhancing arachidonic acid release. Blood 81(9):2329–2338PubMed
Mehta PJ, Chapman S, Jayam-Trouth A, Kurukumbi M (2012) Acute ischemic stroke secondary to iron deficiency anemia: a case report. Case Rep Neurol Med 2012
Mendis S (2013) Stroke disability and rehabilitation of stroke: World Health Organization perspective. Int J Stroke 8(1):3–4CrossRefPubMed
Millan M, Sobrino T, Castellanos M et al (2007) Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke. Stroke 38(1):90–95CrossRefPubMed
Millerot-Serrurot E, Bertrand N, Mossiat C et al (2008) Temporal changes in free iron levels after brain ischemia: relevance to the timing of iron chelation therapy in stroke. Neurochem Int 52(8):1442–1448CrossRefPubMed
Munshi A, Babu S, Kaul S, Shafi G, Rajeshwar K, Alladi S, Jyothy A (2009) Depletion of serum zinc in ischemic stroke patients. Method Find Exp Clin 32(6):433–436
Nielsen FH (2014) Update on human health effects of boron. J Trace Elem Med Bio 28(4):383–387CrossRef
Olabanji SO, Ige AO, Mazzoli C, Ceccato D, Ajayi EOB, De Poli M, Moschini G (2005) Quantitative elemental analysis of an industrial mineral talc, using accelerator-based analytical technique. Nucl Instrum Methods Phys Res, Sect B 240(1):327–332CrossRef
Ozcelik D, Uzun H (2009) Copper intoxication; antioxidant defenses and oxidative damage in rat brain. Biol Trace Elem Res 127(1):45–52CrossRefPubMed
Penland JG (1998) The importance of boron nutrition for brain and psychological function. BiolTrace Elem Res 66(1–3):299–317CrossRef
Petrova J, Manolov V, Vasilev V, Tzatchev K, Marinov B (2016) Ischemic stroke, inflammation, iron overload–connection to a hepcidin. Int J Stroke 11(1):16–17CrossRef
Rosamond W, Flegal K, Furie K et al (2008) Heart disease and stroke statistics—2008 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 117:e25–146CrossRefPubMed
Saenger AK, Christenson RH (2010) Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. ClinChem 56(1):21–33
Saito I, Asano T, Sano K, Takakura K, Abe H, Yoshimoto T, Kikuchi H, Ohta T, Ishibashi S (1998) Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery 42(2):269–277CrossRefPubMed
Salemi G, Gueli MC, D’Amelio M et al (2009) Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B12 in the acute phase of atherothrombotic stroke. Neurol Sci 30(4):361–364CrossRefPubMed
Sarti C, Rastenyte D, Cepaitis Z, Tuomilehto J (2000) International trends in mortality from stroke, 1968 to 1994. Stroke 31:1588–1501CrossRefPubMed
Savaskan NE, Hore N, Eyupoglu IY (2012) Selenium and selenoproteins in neuroprotection and neuronal cell death. In: Li YV, Zhang JH (eds) Metal ion in stroke. Springer, New York, pp 525–536CrossRef
Selim MH, Ratan RR (2004) The role of iron neurotoxicity in ischemic stroke. Ageing Res Rev 3(3):345–353CrossRefPubMed
Shioda N, Morioka M, Fukunaga K (2008) Vanadium compounds enhance adult neurogenesis after brain ischemia. Yakugakuzasshi: Journal of the Pharmaceutical Society of Japan 128(3):413–417
Shrivastava K, Shukla D, Bansal A, Sairam M, Banerjee PK, Ilavazhagan G (2008) Neuroprotective effect of cobalt chloride on hypobaric hypoxia-induced oxidative stress. Neurochem Int 52(3):368–375CrossRefPubMed
Silva GS, Koroshetz WJ, González RG, Schwamm LH (2011) Causes of ischemic stroke. In: González RG, Hirsch JA, Lev MH, Schaefer PW, Schwamm LH (eds) Acute ischemic stroke. Springer, Berlin, Heidelberg, pp 25–42CrossRef
Singhal AB, Lo EH, Dalkara T, Moskowitz MA (2011) Ischemic stroke: basic pathophysiology and neuroprotective strategies. In: González RG, Hirsch JA, Lev MH, Schaefer PW, Schwamm LH (eds) Acute ischemic stroke. Springer, Berlin, pp 1–24CrossRef
Słomka A, Świtońska M, Żekanowska E (2015) Hepcidin levels are increased in patients with acute ischemic stroke: preliminary report. J Stroke Cerebrovasc 24(7):1570–1576CrossRef
Stokowska A, Olsson S, Holmegaard L, Jood K, Blomstrand C, Jern C, Pekna M (2011) Plasma C3 and C3a levels in cryptogenic and large-vessel disease stroke: associations with outcome. Cerebrovasc Dis 32(2):114–122CrossRefPubMed
Strydom C, Robinson C, Pretorius E, Whitcutt JM, Marx J, Bornman MS (2007) The effect of selected metals on the central metabolic pathways in biology: a review. Water SA 32(4):543–554CrossRef
Subrahmanyam G, Sankar KD, Ramalingam K, Bhanu PS (2013) Hypolipidemic and anti-atherogenic effects of vanadium in high-fat diet rabbits. Trace Elem Electroly 30(3):114–121CrossRef
Suenaga A, Ueki H (2004) Effect of orthovanadate on platelet aggregation induced by platelet-activating factor. Biol Pharm Bull 27(11):1859–1863CrossRefPubMed
Tamer G, Mert M, Tamer I, Mesci B, Kilic D, Arik S (2011) Effects of thyroid autoimmunity on abdominal obesity and hyperlipidaemia. Endokrynol Pol 62(5):421–428PubMed
Vahidnia A, Van der Voet GB, De Wolff FA (2007) Arsenic neurotoxicity—a review. Hum Exp Toxicol 26(10):823–832CrossRefPubMed
Vila N, Castillo J, Dávalos A, Chamorro Á (2000) Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31(10):2325–2329CrossRefPubMed
Vinceti M, Mandrioli J, Borella P, Michalke B, Tsatsakis A, Finkelstein Y (2014) Selenium neurotoxicity in humans: bridging laboratory and epidemiologic studies. Toxicol Lett 230(2):295–303CrossRefPubMed
Wallace JMW, Hannon-Fletcher MPA, Robson PJ, Gilmore WS, Hubbard SA, Strain JJ (2002) Boron supplementation and activated factor VII in healthy men. Eur J Clin Nutr 56:1102–1107CrossRefPubMed
Wei WQ, Abnet CC, Qiao YL et al (2004) Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J ClinNutr 79(1):80–85
Weissman JD, Khunteev GA, Heath R, Dambinova SA (2011) NR2 antibodies: risk assessment of transient ischemic attack (TIA)/stroke in patients with history of isolated and multiple cerebrovascular events. J NeurolSci 300(1):97–102
Yiping T, Yuping W, Jianying C, Zhifeng R (1997) Study on the content of vanadium, molybdenum, barium, aluminium, strontium in serum of sufferers from apoplectic stroke. Trace Elements Science 2:003
Young IS, McEneny J (2001) Lipoprotein oxidation and atherosclerosis. Biochem Soc T 29(2):358–362CrossRef
Yousuf S, Atif F, Ahmad M, Hoda MN, Khan MB, Ishrat T, Islam F (2007) Selenium plays a modulatory role against cerebral ischemia-induced neuronal damage in rat hippocampus. Brain Res 1147:218–225CrossRefPubMed
Zwolak I (2014) Vanadium carcinogenic, immunotoxic and neurotoxic effects: a review of in vitro studies. Toxicol Mech Method 24(1):1–12CrossRef
Metadata
Title
Serum trace elements are associated with hemostasis, lipid spectrum and inflammatory markers in men suffering from acute ischemic stroke
Authors
Anatoly V. Skalny
Lydmila L. Klimenko
Aliya A. Turna
Maria N. Budanova
Ivan S. Baskakov
Marina S. Savostina
Aksana N. Mazilina
Anatoly I. Deyev
Margarita G. Skalnaya
Alexey A. Tinkov
Publication date
01-06-2017
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 3/2017
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-017-9967-6

Other articles of this Issue 3/2017

Metabolic Brain Disease 3/2017 Go to the issue

Original Article

MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective

Original Article

Association between hyperhomocysteinemia and stroke with atherosclerosis and small artery occlusion depends on homocysteine metabolism-related vitamin levels in Chinese patients with normal renal function

Short Communication

A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency

Original Article

Frequency-dependent changes in the amplitude of low-frequency fluctuations in patients with Wilson’s disease: a resting-state fMRI study

Original Article

Ras-like without CAAX 2 (RIT2): a susceptibility gene for autism spectrum disorder

Original Article

Peripheral and central administration of T3 improved the histological changes, memory and the dentate gyrus electrophysiological activity in an animal model of Alzheimer’s disease